Consequently, overexpression of SORLA in neuronal and non-neuronal cell lines blocks APP processing and reduces Aβ production [4, 68, 76], while loss of SORLA increases Aβ levels and senile plaque burden in several mouse models of AD [4, 22, 77]. Here, APP is linked to Alzheimer disease.